BLV, a deltaretrovirus closely related to HTLV-1, manipulates host apoptotic pathways during infection to favor the survival of infected cells, mainly through the upregulation of anti-apoptotic BCL-2 affiliated proteins such as BCL-2 and MCL-1, which protect infected lymphocytes from programmed cell death [12]. Here, BCL2 is linked to infection.